Cystic Fibrosis Foundation Invests $6M in Carbon Biosciences to Advance New Gene Therapy Approach for Cystic Fibrosis
Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to...